河北医科大学学报 ›› 2021, Vol. 42 ›› Issue (5): 520-524.doi: 10.3969/j.issn.1007-3205.2021.05.006

• • 上一篇    下一篇

脾脏在慢性应激促肝癌进展中的作用

  

  1. 1.西安交通大学第二附属医院肿瘤外科,生物诊断治疗国家地方联合工程研究中心,陕西 西安 710004;
    2.西安交通大学第二附属医院胸外科,陕西 西安 710004
  • 出版日期:2021-05-25 发布日期:2021-05-28
  • 作者简介:江维(1990-),男,四川安岳人,西安交通大学第二附属医院助理研究员,医学博士,从事肿瘤免疫、神经内分泌免疫异常研究。
  • 基金资助:
    国家自然科学基金项目(91842307); 陕西省自然科学基金项目(2021JQ-410);西安交通大学第二附属医院青年基金项目(YJ (QN) 2018.07)

The role of the spleen in progression of hepatic carcinoma induced by chronic stress


  1. 1.Department of Oncology, National & Local Joint Engineering Research Center of Biodiagnosis
    and Biotherapy, the Second Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710004, China;
    2.Department of Thoracic Surgery, the Second Affiliated Hospital of Xi′an
    Jiaotong University, Xi′an 710004, China
  • Online:2021-05-25 Published:2021-05-28

摘要: 目的  探讨脾脏在慢性应激促肝癌进展中的作用。
方法  建立H22肝癌细胞皮下种植瘤模型,通过慢性束缚应激模型探索慢性应激对肝癌进展的影响;通过流式细胞术检测外周血和肿瘤组织CD11b+Ly6C+CCR2+单核细胞的比例;通过脾切除考察脾脏在慢性应激促肝癌进展中的作用。
结果  应激组肿瘤重量明显高于对照组,外周血CD11b+Ly6C+CCR2+单核细胞的比例明显高于对照组,差异有统计学意义(P<0.05);对照组和应激组肿瘤组织中CD11b+Ly6C+CCR2+单核细胞的比例差异无统计学意义(P>0.05)。假手术应激组肿瘤重量明显高于假手术组和脾切除应激组,外周血CD11b+Ly6C+CCR2+单核细胞的比例明显高于假手术组和脾切除应激组,差异有统计学意义(P<0.01);假手术组和脾切除应激组肿瘤重量、外周血CD11b+Ly6C+CCR2+单核细胞的比例差异无统计学意义(P>0.05);假手术组、假手术应激组和脾切除应激组肿瘤组织中CD11b+Ly6C+CCR2+单核细胞的比例差异无统计学意义(P>0.05)。
结论  慢性应激促进肝癌进展并抑制抗肿瘤免疫,脾切除可能通过降低CD11b+Ly6C+CCR2+单核细胞比例而减缓慢性应激小鼠肝脏的进展。

关键词: 肝肿瘤, 脾, 慢性应激

Abstract: Objective  To investigate the role of the spleen in the progression of hepatic carcinoma induced by chronic stress.
Methods  The murine H22 subcutaneous hepatoma model was established. Chronic restraint stress(CRS) model was used to explore the role of chronic stress in the progression of hepatic carcinoma. The proportion of CD11b+Ly6C+CCR2+ monocytes in peripheral blood and tumor tissue was detected by flow cytometry, and the role of the spleen in the progression of hepatic carcinoma induced by chronic stress was investigated by splenectomy.
Results  The tumor weight was significantly greater, and the proportion of CD11b+Ly6C+CCR2+ monocytes in peripheral blood were significantly increased in stress group, as compared with control group, suggesting significant differences(P<0.05). However, the proportion of CD11b+Ly6C+CCR2+ monocytes in tumor tissue of stress group did not change significantly compared with control group(P>0.05). The tumor weight and the proportion of CD11b+Ly6C+CCR2+ monocytes in peripheral blood in sham operation stress group were significantly higher than those in sham operation group and splenectomy stress group(P<0.01) while there were no significant differences in the tumor weight and the proportion of CD11b+Ly6C+CCR2+ monocytes in the peripheral blood between sham operation stress group and splenectomy stress group(P>0.05). The proportion of CD11b+Ly6C+CCR2+ monocytes in tumor tissue in sham operation stress group and splenectomy stress group did not change significantly compared with sham operation group(P>0.05).
Conclusion  Chronic stress could promote the progression of hepatic carcinoma and inhibit the activity of anti-tumor immunity. Splenectomy could slow down the progression of hepatic carcinoma induced by chronic stress possibly by reducing the proportion of CD11b+Ly6C+CCR2+ monocytes.

Key words: liver neoplasms, spleen, chronic stress